Deals In March MyungMoon Bio To Sell ACell's Wound Matrix Products In South Korea ACell Inc. granted MyungMoon Bio Co. Ltd. exclusive rights to market and distribute its wound management matrix pr
The authors of the randomized CLOTBUST ER trial of Cerevast Therapeutics Inc. ’s sonothrombolysis system believe the pulsed-wave intracranial ultrasound technology could be used to improve the expo
Eton Pharmaceuticals Inc. has appointed Sean Brynjelsen CEO. Brynjelsen brings more than 20 years of experience in the industry to the company and previously worked at pharma companies, including
Cerevast Therapeutics Inc. has enrolled over 650 subjects in its global, pivotal Phase III trial of Clotbust ER , a head-frame worn by a stroke patient in the emergency room that delivers ultrasoni